APO Research
Talk to an analyst

APO RESEARCH · REPORT

Prilocaine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Prilocaine Market Outlook and Growth Opportunities 2026

26 December 2025193 pages

Choose your research edition.

Industry ResearchPrilocaine Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Prilocaine Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Prilocaine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Prilocaine Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Prilocaine Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Prilocaine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Prilocaine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Prilocaine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Prilocaine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Prilocaine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Prilocaine market include Active Biopharma Corp, Anant Pharmaceuticals, B. Braun, ANXIN PHARMACEUTICAL, Yeasen Biotechnology, Nanjing HuaNuo Bio-Pharmaceutical Technology, Beijing Vokai Biotechnology and Haisco Pharmaceutical Group, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Prilocaine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Prilocaine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Prilocaine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Prilocaine market size, projected growth trends, production technologies, key applications, and end-use industries.

Prilocaine Segment by Company

Active Biopharma Corp

Anant Pharmaceuticals

B. Braun

ANXIN PHARMACEUTICAL

Yeasen Biotechnology

Nanjing HuaNuo Bio-Pharmaceutical Technology

Beijing Vokai Biotechnology

Haisco Pharmaceutical Group

Prilocaine Segment by Type

3% Solution

2% Solution

1% Solution

Other

Prilocaine Segment by Application

Public Hospital

Private Hospital

Prilocaine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Prilocaine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Prilocaine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Prilocaine significant trends, drivers, influence factors in global and regions.

6. To analyze Prilocaine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prilocaine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Prilocaine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prilocaine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Prilocaine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Prilocaine industry.

Chapter 3: Detailed analysis of Prilocaine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Prilocaine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Prilocaine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Prilocaine Industry Trends Table 2. Prilocaine Industry Drivers Table 3. Prilocaine Industry Opportunities and Challenges Table 4. Prilocaine Industry Restraints Table 5. Global Prilocaine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Prilocaine Revenue Share by Company (2021-2026) Table 7. Global Prilocaine Sales Volume by Company (Kg) & (2021-2026) Table 8. Global Prilocaine Sales Volume Share by Company (2021-2026) Table 9. Global Prilocaine Average Price (US$/Kg) of Company (2021-2026) Table 10. Global Prilocaine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Prilocaine Key Company Manufacturing Base & Headquarters Table 12. Global Prilocaine Company, Product Type & Application Table 13. Global Prilocaine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Prilocaine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 3% Solution Table 18. Significant Companies of 2% Solution Table 19. Significant Companies of 1% Solution Table 20. Significant Companies of Other Table 21. Global Prilocaine Sales Volume by Type 2021 VS 2025 VS 2032 (Kg) Table 22. Global Prilocaine Sales Volume by Type (2021-2026) & (Kg) Table 23. Global Prilocaine Sales Volume by Type (2027-2032) & (Kg) Table 24. Global Prilocaine Sales Volume Share by Type (2021-2026) Table 25. Global Prilocaine Sales Volume Share by Type (2027-2032) Table 26. Global Prilocaine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Prilocaine Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Prilocaine Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Prilocaine Sales Value Share by Type (2021-2026) Table 30. Global Prilocaine Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Public Hospital Table 32. Significant Companies of Private Hospital Table 33. Global Prilocaine Sales Volume by Application 2021 VS 2025 VS 2032 (Kg) Table 34. Global Prilocaine Sales Volume by Application (2021-2026) & (Kg) Table 35. Global Prilocaine Sales Volume by Application (2027-2032) & (Kg) Table 36. Global Prilocaine Sales Volume Share by Application (2021-2026) Table 37. Global Prilocaine Sales Volume Share by Application (2027-2032) Table 38. Global Prilocaine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Prilocaine Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Prilocaine Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Prilocaine Sales Value Share by Application (2021-2026) Table 42. Global Prilocaine Sales Value Share by Application (2027-2032) Table 43. Global Prilocaine Sales by Region: 2021 VS 2025 VS 2032 (Kg) Table 44. Global Prilocaine Sales by Region (2021-2026) & (Kg) Table 45. Global Prilocaine Sales Market Share by Region (2021-2026) Table 46. Global Prilocaine Sales by Region (2027-2032) & (Kg) Table 47. Global Prilocaine Sales Market Share by Region (2027-2032) Table 48. Global Prilocaine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Prilocaine Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Prilocaine Sales Value Share by Region (2021-2026) Table 51. Global Prilocaine Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Prilocaine Sales Value Share by Region (2027-2032) Table 53. Global Prilocaine Market Average Price (US$/Kg) by Region (2021-2026) Table 54. Global Prilocaine Market Average Price (US$/Kg) by Region (2027-2032) Table 55. Global Prilocaine Sales by Country: 2021 VS 2025 VS 2032 (Kg) Table 56. Global Prilocaine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Prilocaine Sales by Country (2021-2026) & (Kg) Table 58. Global Prilocaine Sales Market Share by Country (2021-2026) Table 59. Global Prilocaine Sales by Country (2027-2032) & (Kg) Table 60. Global Prilocaine Sales Market Share by Country (2027-2032) Table 61. Global Prilocaine Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Prilocaine Sales Value Market Share by Country (2021-2026) Table 63. Global Prilocaine Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Prilocaine Sales Value Market Share by Country (2027-2032) Table 65. Active Biopharma Corp Company Information Table 66. Active Biopharma Corp Business Overview Table 67. Active Biopharma Corp Prilocaine Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 68. Active Biopharma Corp Prilocaine Product Portfolio Table 69. Active Biopharma Corp Recent Development Table 70. Anant Pharmaceuticals Company Information Table 71. Anant Pharmaceuticals Business Overview Table 72. Anant Pharmaceuticals Prilocaine Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 73. Anant Pharmaceuticals Prilocaine Product Portfolio Table 74. Anant Pharmaceuticals Recent Development Table 75. B. Braun Company Information Table 76. B. Braun Business Overview Table 77. B. Braun Prilocaine Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 78. B. Braun Prilocaine Product Portfolio Table 79. B. Braun Recent Development Table 80. ANXIN PHARMACEUTICAL Company Information Table 81. ANXIN PHARMACEUTICAL Business Overview Table 82. ANXIN PHARMACEUTICAL Prilocaine Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 83. ANXIN PHARMACEUTICAL Prilocaine Product Portfolio Table 84. ANXIN PHARMACEUTICAL Recent Development Table 85. Yeasen Biotechnology Company Information Table 86. Yeasen Biotechnology Business Overview Table 87. Yeasen Biotechnology Prilocaine Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 88. Yeasen Biotechnology Prilocaine Product Portfolio Table 89. Yeasen Biotechnology Recent Development Table 90. Nanjing HuaNuo Bio-Pharmaceutical Technology Company Information Table 91. Nanjing HuaNuo Bio-Pharmaceutical Technology Business Overview Table 92. Nanjing HuaNuo Bio-Pharmaceutical Technology Prilocaine Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 93. Nanjing HuaNuo Bio-Pharmaceutical Technology Prilocaine Product Portfolio Table 94. Nanjing HuaNuo Bio-Pharmaceutical Technology Recent Development Table 95. Beijing Vokai Biotechnology Company Information Table 96. Beijing Vokai Biotechnology Business Overview Table 97. Beijing Vokai Biotechnology Prilocaine Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 98. Beijing Vokai Biotechnology Prilocaine Product Portfolio Table 99. Beijing Vokai Biotechnology Recent Development Table 100. Haisco Pharmaceutical Group Company Information Table 101. Haisco Pharmaceutical Group Business Overview Table 102. Haisco Pharmaceutical Group Prilocaine Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 103. Haisco Pharmaceutical Group Prilocaine Product Portfolio Table 104. Haisco Pharmaceutical Group Recent Development Table 105. Key Raw Materials Table 106. Raw Materials Key Suppliers Table 107. Prilocaine Distributors List Table 108. Prilocaine Customers List Table 109. Research Programs/Design for This Report Table 110. Authors List of This Report Table 111. Secondary Sources Table 112. Primary Sources List of Figures Figure 1. Prilocaine Product Image Figure 2. Global Prilocaine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Prilocaine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Prilocaine Sales (2021-2032) & (Kg) Figure 5. Global Prilocaine Sales Average Price (US$/Kg) & (2021-2032) Figure 6. Global Prilocaine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 3% Solution Image Figure 10. 2% Solution Image Figure 11. 1% Solution Image Figure 12. Other Image Figure 13. Global Prilocaine Sales Volume by Type (2021 VS 2025 VS 2032) & (Kg) Figure 14. Global Prilocaine Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Prilocaine Sales Volume Share by Type (2021-2032) Figure 16. Global Prilocaine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Prilocaine Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Prilocaine Sales Value Share by Type (2021-2032) Figure 19. Public Hospital Image Figure 20. Private Hospital Image Figure 21. Global Prilocaine Sales Volume by Application (2021 VS 2025 VS 2032) & (Kg) Figure 22. Global Prilocaine Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Prilocaine Sales Volume Share by Application (2021-2032) Figure 24. Global Prilocaine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Prilocaine Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Prilocaine Sales Value Share by Application (2021-2032) Figure 27. Global Prilocaine Sales by Region: 2021 VS 2025 VS 2032 (Kg) Figure 28. Global Prilocaine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Prilocaine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Prilocaine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Prilocaine Sales Value (2021-2032) & (US$ Million) Figure 32. North America Prilocaine Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Prilocaine Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Prilocaine Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Prilocaine Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Prilocaine Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Prilocaine Sales Value (2021-2032) & (US$ Million) Figure 38. South America Prilocaine Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Prilocaine Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Prilocaine Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Prilocaine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Prilocaine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Prilocaine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Prilocaine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Prilocaine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Prilocaine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Prilocaine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Prilocaine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Prilocaine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Prilocaine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Prilocaine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Prilocaine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Prilocaine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Prilocaine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Prilocaine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Prilocaine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Prilocaine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Prilocaine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Prilocaine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Prilocaine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Prilocaine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Prilocaine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Prilocaine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Prilocaine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Prilocaine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Prilocaine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Prilocaine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Prilocaine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Prilocaine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Prilocaine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Prilocaine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Prilocaine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Prilocaine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Prilocaine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Prilocaine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Prilocaine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Prilocaine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Prilocaine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Prilocaine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Prilocaine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Prilocaine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Prilocaine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Prilocaine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Prilocaine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Prilocaine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Prilocaine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Prilocaine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Prilocaine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Prilocaine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Prilocaine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Prilocaine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Prilocaine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Prilocaine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Prilocaine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Prilocaine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Prilocaine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Prilocaine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Prilocaine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Prilocaine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Prilocaine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Prilocaine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Prilocaine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Prilocaine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Prilocaine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Prilocaine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Prilocaine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Prilocaine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Prilocaine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Prilocaine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Prilocaine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Prilocaine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Prilocaine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Prilocaine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Prilocaine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Prilocaine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Prilocaine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Prilocaine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Prilocaine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Prilocaine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Prilocaine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Prilocaine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Prilocaine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Prilocaine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Prilocaine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Prilocaine Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Prilocaine Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • 3% Solution
  • 2% Solution
  • 1% Solution
  • Other
Applications
  • Public Hospital
  • Private Hospital
Companies covered
  • Active Biopharma Corp
  • Anant Pharmaceuticals
  • B. Braun
  • ANXIN PHARMACEUTICAL
  • Yeasen Biotechnology
  • Nanjing HuaNuo Bio-Pharmaceutical Technology
  • Beijing Vokai Biotechnology
  • Haisco Pharmaceutical Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Prilocaine Sales Value (2021-2032)
  4. 1.2.2 Global Prilocaine Sales Volume (2021-2032)
  5. 1.2.3 Global Prilocaine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Prilocaine Market Dynamics
  1. 2.1 Prilocaine Industry Trends
  2. 2.2 Prilocaine Industry Drivers
  3. 2.3 Prilocaine Industry Opportunities and Challenges
  4. 2.4 Prilocaine Industry Restraints
3 Prilocaine Market by Company
  1. 3.1 Global Prilocaine Company Revenue Ranking in 2025
  2. 3.2 Global Prilocaine Revenue by Company (2021-2026)
  3. 3.3 Global Prilocaine Sales Volume by Company (2021-2026)
  4. 3.4 Global Prilocaine Average Price by Company (2021-2026)
  5. 3.5 Global Prilocaine Company Ranking (2024-2026)
  6. 3.6 Global Prilocaine Company Manufacturing Base and Headquarters
  7. 3.7 Global Prilocaine Company Product Type and Application
  8. 3.8 Global Prilocaine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Prilocaine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Prilocaine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Prilocaine Market by Type
  1. 4.1 Prilocaine Type Introduction
  2. 4.1.1 3% Solution
  3. 4.1.2 2% Solution
  4. 4.1.3 1% Solution
  5. 4.1.4 Other
  6. 4.2 Global Prilocaine Sales Volume by Type
  7. 4.2.1 Global Prilocaine Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Prilocaine Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Prilocaine Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Prilocaine Sales Value by Type
  11. 4.3.1 Global Prilocaine Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Prilocaine Sales Value by Type (2021-2032)
  13. 4.3.3 Global Prilocaine Sales Value Share by Type (2021-2032)
5 Prilocaine Market by Application
  1. 5.1 Prilocaine Application Introduction
  2. 5.1.1 Public Hospital
  3. 5.1.2 Private Hospital
  4. 5.2 Global Prilocaine Sales Volume by Application
  5. 5.2.1 Global Prilocaine Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Prilocaine Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Prilocaine Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Prilocaine Sales Value by Application
  9. 5.3.1 Global Prilocaine Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Prilocaine Sales Value by Application (2021-2032)
  11. 5.3.3 Global Prilocaine Sales Value Share by Application (2021-2032)
6 Prilocaine Regional Sales and Value Analysis
  1. 6.1 Global Prilocaine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Prilocaine Sales by Region (2021-2032)
  3. 6.2.1 Global Prilocaine Sales by Region: 2021-2026
  4. 6.2.2 Global Prilocaine Sales by Region (2027-2032)
  5. 6.3 Global Prilocaine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Prilocaine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Prilocaine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Prilocaine Sales Value by Region (2027-2032)
  9. 6.5 Global Prilocaine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Prilocaine Sales Value (2021-2032)
  12. 6.6.2 North America Prilocaine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Prilocaine Sales Value (2021-2032)
  15. 6.7.2 Europe Prilocaine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Prilocaine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Prilocaine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Prilocaine Sales Value (2021-2032)
  21. 6.9.2 South America Prilocaine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Prilocaine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Prilocaine Sales Value Share by Country, 2025 VS 2032
7 Prilocaine Country-level Sales and Value Analysis
  1. 7.1 Global Prilocaine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Prilocaine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Prilocaine Sales by Country (2021-2032)
  4. 7.3.1 Global Prilocaine Sales by Country (2021-2026)
  5. 7.3.2 Global Prilocaine Sales by Country (2027-2032)
  6. 7.4 Global Prilocaine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Prilocaine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Prilocaine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Prilocaine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Prilocaine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Prilocaine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Prilocaine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Prilocaine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Prilocaine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Prilocaine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Prilocaine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Prilocaine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Prilocaine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Prilocaine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Prilocaine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Prilocaine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Prilocaine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Prilocaine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Prilocaine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Prilocaine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Prilocaine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Prilocaine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Prilocaine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Prilocaine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Prilocaine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Prilocaine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Prilocaine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Prilocaine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Prilocaine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Prilocaine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Prilocaine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Prilocaine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Prilocaine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Prilocaine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Prilocaine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Prilocaine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Prilocaine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Prilocaine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Prilocaine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Prilocaine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Prilocaine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Prilocaine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Prilocaine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Prilocaine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Prilocaine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Prilocaine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Prilocaine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Prilocaine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Prilocaine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Prilocaine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Prilocaine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Prilocaine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Prilocaine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Prilocaine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Prilocaine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Prilocaine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Prilocaine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Prilocaine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Prilocaine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Prilocaine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Prilocaine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Prilocaine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Prilocaine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Prilocaine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Prilocaine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Prilocaine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Prilocaine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Prilocaine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Prilocaine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Prilocaine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Prilocaine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Prilocaine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Prilocaine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Prilocaine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Prilocaine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Prilocaine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Prilocaine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Prilocaine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Prilocaine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Prilocaine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Prilocaine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Prilocaine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Prilocaine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Prilocaine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Prilocaine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Prilocaine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Prilocaine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Active Biopharma Corp
  2. 8.1.1 Active Biopharma Corp Company Information
  3. 8.1.2 Active Biopharma Corp Business Overview
  4. 8.1.3 Active Biopharma Corp Prilocaine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Active Biopharma Corp Prilocaine Product Portfolio
  6. 8.1.5 Active Biopharma Corp Recent Developments
  7. 8.2 Anant Pharmaceuticals
  8. 8.2.1 Anant Pharmaceuticals Company Information
  9. 8.2.2 Anant Pharmaceuticals Business Overview
  10. 8.2.3 Anant Pharmaceuticals Prilocaine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Anant Pharmaceuticals Prilocaine Product Portfolio
  12. 8.2.5 Anant Pharmaceuticals Recent Developments
  13. 8.3 B. Braun
  14. 8.3.1 B. Braun Company Information
  15. 8.3.2 B. Braun Business Overview
  16. 8.3.3 B. Braun Prilocaine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 B. Braun Prilocaine Product Portfolio
  18. 8.3.5 B. Braun Recent Developments
  19. 8.4 ANXIN PHARMACEUTICAL
  20. 8.4.1 ANXIN PHARMACEUTICAL Company Information
  21. 8.4.2 ANXIN PHARMACEUTICAL Business Overview
  22. 8.4.3 ANXIN PHARMACEUTICAL Prilocaine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 ANXIN PHARMACEUTICAL Prilocaine Product Portfolio
  24. 8.4.5 ANXIN PHARMACEUTICAL Recent Developments
  25. 8.5 Yeasen Biotechnology
  26. 8.5.1 Yeasen Biotechnology Company Information
  27. 8.5.2 Yeasen Biotechnology Business Overview
  28. 8.5.3 Yeasen Biotechnology Prilocaine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Yeasen Biotechnology Prilocaine Product Portfolio
  30. 8.5.5 Yeasen Biotechnology Recent Developments
  31. 8.6 Nanjing HuaNuo Bio-Pharmaceutical Technology
  32. 8.6.1 Nanjing HuaNuo Bio-Pharmaceutical Technology Company Information
  33. 8.6.2 Nanjing HuaNuo Bio-Pharmaceutical Technology Business Overview
  34. 8.6.3 Nanjing HuaNuo Bio-Pharmaceutical Technology Prilocaine Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Nanjing HuaNuo Bio-Pharmaceutical Technology Prilocaine Product Portfolio
  36. 8.6.5 Nanjing HuaNuo Bio-Pharmaceutical Technology Recent Developments
  37. 8.7 Beijing Vokai Biotechnology
  38. 8.7.1 Beijing Vokai Biotechnology Company Information
  39. 8.7.2 Beijing Vokai Biotechnology Business Overview
  40. 8.7.3 Beijing Vokai Biotechnology Prilocaine Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Beijing Vokai Biotechnology Prilocaine Product Portfolio
  42. 8.7.5 Beijing Vokai Biotechnology Recent Developments
  43. 8.8 Haisco Pharmaceutical Group
  44. 8.8.1 Haisco Pharmaceutical Group Company Information
  45. 8.8.2 Haisco Pharmaceutical Group Business Overview
  46. 8.8.3 Haisco Pharmaceutical Group Prilocaine Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Haisco Pharmaceutical Group Prilocaine Product Portfolio
  48. 8.8.5 Haisco Pharmaceutical Group Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Prilocaine Value Chain Analysis
  2. 9.1.1 Prilocaine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Prilocaine Sales Mode & Process
  6. 9.2 Prilocaine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Prilocaine Distributors
  9. 9.2.3 Prilocaine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst